Neuralstem (CUR) Names New CEO Feb 16, 2016 07:35AM
Neuralstem Appoints Richard Daly as President and Chief Executive Officer Feb 16, 2016 07:35AM
Neuralstem Presented Cell Therapy Update At Phacilitate Cell & Gene Therapy World Conference Jan 27, 2016 09:02AM
Neuralstem (CUR) Announces Publication of HK532-IGF-1 Data in Alzheimer's Disease Jan 11, 2016 07:34AM
Neuralstem's Preclinical Alzheimer's Disease Data Published In Stem Cells Translational Medicine Jan 11, 2016 07:32AM


Jan 6, 2016 08:35AM Neuralstem to Present at the Biotech Showcase 2016 Conference in San Francisco
Dec 8, 2015 07:38AM Neuralstem (CUR) Announces Publication of NSI-189 Phase 1b Data; Found to be Well Tolerated at Escalating Doses
Dec 8, 2015 07:32AM Data for Neuralstem's Novel NSI-189 Molecule in Major Depressive Disorder Published in Molecular Psychiatry
Nov 9, 2015 09:03AM Neuralstem Reports Third Quarter 2015 Financial Results
Sep 29, 2015 08:01AM Neuralstem Investigator Provides Phase II Update on ALS Cell Therapy at American Neurological Association Annual Meeting
Sep 24, 2015 09:01AM Neuralstem Investigator to Provide Update on ALS and Alzheimer's at American Neurological Association Annual Meeting
Aug 10, 2015 08:05AM Neuralstem Reports Second Quarter 2015 Financial Results
Jul 23, 2015 07:45AM US District Court Rules In Favor Of Neuralstem In Patent Infringement Case
Jun 29, 2015 09:22AM Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market
Jun 26, 2015 07:32AM Preclinical Data On Neuralstem's Genetically Modified HK532-IGF-1 Stem Cells In Alzheimer's Disease Presented At International Society For Stem Cell Research Annual Meeting
May 8, 2015 07:30AM Neuralstem Reports First Quarter 2015 Financial Results And Provides Business and Clinical Update
May 6, 2015 07:31AM Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer
Mar 16, 2015 07:30AM Neuralstem Reports Fiscal 2014 Fourth Quarter Financial And Year-End Business Results
Mar 12, 2015 06:50AM Neuralstem Announces Topline Results Of Phase II ALS Trial